MEDICINE & HEALTHJohnson & Johns is under investigation by the FBI for possible prior knowledge about dangers linked to one of their medical devices, the laparoscopic power morcellator, which is supposed to provide a minimally invasive alternative to hysterectomies and removal of fibroid tumors, but in reality, may have been spreading dangerous forms of cancers among its patients.
Pharmacyclics will ‘possibly’ be acquired by Johnson & Johnson for $18 Billion Pharmacyclics, the US-based biopharmaceutical organization that develops and commercializes small-molecule drugs for cancer and other diseases, surged to a new high when Bloomberg reported that the company is considering selling itself for $18 billion.